Zulfiqar A Bhutta and colleagues argue that the response to children in fragile and conflict affected settings must move beyond event based framings to tackle cumulative and intergenerational ...

Science 37 is a leading patient access company in clinical research that delivers trials directly to patients' homes.

Age-related memory decline and neurodegenerative diseases like Alzheimer's are often thought of as irreversible.

Age-related memory decline and neurodegenerative diseases like Alzheimer's are often thought of as irreversible. But the ...

CEO Rahul Patel reported strong results, highlighting "total company revenue increased 13% year-over-year, marking our fifth consecutive quarter of double-digit year-over-year growth." Patel ...

Good day, and thank you for standing by. Welcome to Synaptics Second Quarter Fiscal Year 2026 Financial Results Conference Call. [Operator Instructions] Please be advised that today's conference is ...

Munjal Shah: Thank you, Kathy. Good afternoon, and thank you, everyone, for joining us today on Synaptics first quarter fiscal 2025 conference call. My name is Munjal Shah, and I am the Head of ...

Synaptics Incorporated reported its second-quarter fiscal year 2026 earnings on February 5, 2026. The company surpassed analysts’ expectations with an earnings per share (EPS) of $1.21, compared to ...

Synaptics (SYNA) came out with quarterly earnings of $1.21 per share, beating the Zacks Consensus Estimate of $1.15 per share. This compares to earnings of $0.92 per share a year ago. These figures ...